Therapeutic oligonucleotides have become as a new drug class.They are synthetic DNA or RNA that typically between 15 and 50 nucleotide units long.In the pharmacokinetic studies of therapeutic oligonucleotides,the classical method was enzyme-linked immunosorbent assay(ELISA).However,the development of ELISA method was time-consuming and expensive,and has become the bottleneck in the new drug research and development.The technical issues associated with liquid chromatography-mass spectrometry(LC/MS) method in the bioanalysis of oligonucleotides included: limited ionization efficiency,severe matrix effect,incompatibility of chromatographic condition and MS detection,and low sample preparation recovery.However,the development of an LC/MS method was fast,and this method was selective.This review summarized the development and applications of LC/MS method for the quantitation of therapeutic oligonucleotides and characterization of their metabolites in biological samples described in the literatures over the past 15 years.